General MedicationsORALGeneric

LO-BLISOVI FE

NORETHINDRONE ACETATE;ETHINYL ESTRADIOL;FERROUS FUMARATE

Standard Dose

1MG;0.01MG;75MG

Max Dose

Refer to approved labeling

Primary Use

Marketing status: None (Tentative Approval)

Summary

Approval overview LO-BLISOVI FE is listed in Drugs@FDA under application 203113 (ANDA).

Marketing status: None (Tentative Approval) Active ingredient NORETHINDRONE ACETATE;ETHINYL ESTRADIOL;FERROUS FUMARATE Form and strength TABLET;ORAL - 1MG;0.01MG;75MG Sponsor LUPIN LTD Submission history Latest submission status date: 2014-05-12 00:00:00.

Structured Monograph

Clinical summary

Approval overview LO-BLISOVI FE is listed in Drugs@FDA under application 203113 (ANDA). Marketing status: None (Tentative Approval) Active ingredient NORETHINDRONE ACETATE;ETHINYL ESTRADIOL;FERROUS FUMARATE Form and strength TABLET;ORAL - 1MG;0.01MG;75MG Sponsor LUPIN LTD Submission history Latest submission status date: 2014-05-12 00:00:00. Submission type: ORIG.

Monitoring

• Marketing status: None (Tentative Approval)

Interaction Notes

No interaction notes stored yet.